Scott A Rollins - Net Worth and Insider Trading
Scott A Rollins Net Worth
The estimated net worth of Scott A Rollins is at least $2 Million dollars as of 2025-07-23. Scott A Rollins is the Sr. VP Drug Dev. & Proj. Man. of Alexion Pharmaceuticals Inc and owns about 12,400 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $2 Million. Details can be seen in Scott A Rollins's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott A Rollins has not made any transactions after 2005-06-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Scott A Rollins
Scott A Rollins Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott A Rollins owns 1 companies in total, including Alexion Pharmaceuticals Inc (ALXN) .
Click here to see the complete history of Scott A Rollins’s form 4 insider trades.
Insider Ownership Summary of Scott A Rollins
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2005-06-08 | Sr. VP Drug Dev. & Proj. Man. |
Scott A Rollins Latest Holdings Summary
Scott A Rollins currently owns a total of 1 stock. Scott A Rollins owns 12,400 shares of Alexion Pharmaceuticals Inc (ALXN) as of June 8, 2005, with a value of $2 Million.
Latest Holdings of Scott A Rollins
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2005-06-08 | 12,400 | 182.50 | 2,263,000 |
Holding Weightings of Scott A Rollins
Scott A Rollins Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott A Rollins has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 7,600 shares on June 8, 2005, which brought Scott A Rollins around $42,275.
Insider Trading History of Scott A Rollins
- 1
Scott A Rollins Trading Performance
Scott A Rollins Ownership Network
Ownership Network List of Scott A Rollins
Ownership Network Relation of Scott A Rollins
Scott A Rollins Owned Company Details
What does Alexion Pharmaceuticals Inc do?
Who are the key executives at Alexion Pharmaceuticals Inc?
Scott A Rollins is the Sr. VP Drug Dev. & Proj. Man. of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Chief Commercial Officer Brian Goff .
Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alexion Pharmaceuticals Inc Insider Transactions
Scott A Rollins Mailing Address
Above is the net worth, insider trading, and ownership report for Scott A Rollins. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Scott A Rollins's mailing address is: C/o Alexion Pharmaceuticals Inc 352 Knotter Drive Cheshire Ct 06410.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
